SB 212 Failed
Enacting the prescription drug cost and affordability review act to establish the prescription drug pricing board and prescription drug affordability stakeholder council to review the cost of prescription medications and establish upper payment limits for certain prescription drugs.
Introduced
In Committee
Floor
Crossed Over
Passed
Enacted
Apr 10, 2026 · Senate
Died in Committee
Feb 6, 2025 · Senate
Referred to Senate Committee on Financial Institutions and Insurance
Feb 5, 2025 · Senate
Introduced